Zynex Corp (ZYXI) - Koefisien utang jangka dawa marang modal

Lambang korporat lan logo Zynex, Inc. (ZYXI)

Zynex, Inc. (ZYXI) relies on external component suppliers while performing the final assembly of electrotherapy devices in-house. The long-term debt-to-equity ratio trend illustrates the financial leverage, where 0.00 is recorded as the baseline value. Critically assessing expansion through agent recruitment and margin growth, one should note the risks of dependency on the NexWave home rehabilitation ecosystem they have established.

ZYXI Zynex Medical: Utang jangka dawa marang ekuitas ing interval 04.07.2022 - 03.01.2026
Barang utama Zynex Corp

An investor is assessing the long-term sustainability of Zynex, Inc. (ZYXI) through an analysis of its credit load. This metric compares the volume of liabilities with a maturity of more than one year against equity. The trend in the long-term debt-to-equity ratio reflects the business's degree of dependence on external financing. A decrease in this ratio minimizes the risk of default. Financial autonomy is critically important for Zynex, Inc. (ZYXI) as it diversifies into the respiratory monitoring segment amid the saturation of the electrostimulation market.

Perusahaan pesaing

DXCM (DexCom Inc) - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang modal PEN|NOVT (Novanta Photonics) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal HAE (Haemonetics Corporation)|inspiresleep.com (INSP) - Kewajiban jangka dawa marang modal|PRCT - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal CNMD (CONMED Corp)|PLSE: Utang jangka dawa marang modal|InMode MD (INMD) - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Picard Medical Inc|surmodics.com - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal SENS|NPCE - Kewajiban jangka dawa marang modal|Tactile Medical - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal SANUWAVE Health Inc SNWV|OM: Rasio utang jangka dawa marang ekuitas|Electromed, Inc. - Rasio silihan jangka dawa marang modal|LNSR: Utang jangka dawa marang modal|RCEL - Rasio tanggungan utang jangka dawa marang modal|PROF (Profound Medical Corp) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Baird Medical Corp (BDMD)|Rasio utang jangka dawa marang ekuitas EDAP (EDAP TMS S.A.)|APYX (apyxmedical.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas IceCure Medical ICCM|LUNG - Rasio utang jangka dawa marang ekuitas|TELA Bio Corp - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Cytosorbents|SRTS: Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal ECOR|RBOT (Vicarious Surgical Inc) - Utang jangka dawa marang modal|Inspira Technologies Oxy B.H.N. Ltd (IINN) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang modal ICU|Rasio utang jangka dawa marang ekuitas iridex.com IRIX|Utang jangka dawa marang modal INBS (Intelligent Bio Solutions Inc.)|Utang jangka dawa marang modal Beyond Air Inc XAIR|PFSA - Utang jangka dawa marang ekuitas|SSKN: Utang jangka dawa marang ekuitas|GCTK (GlucoTrack) - Rasio utang jangka dawa marang ekuitas|NanoVibronix Inc. - Koefisien utang jangka dawa marang modal|VERO (Venus Concept Inc.) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal nuwellis.com NUWE|Utang jangka dawa marang ekuitas Aethlon Medical, Inc. (AEMD)|asensus.com (ASXC) - Tanggungan utang jangka dawa marang ekuitas|Avinger, Inc - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal BioSig Technologies Inc. BSGM|Cutera, Inc. - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal knowlabs.co KNW|Inari Medical (NARI) - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang ekuitas NVRO (Nevro Corp)|Utang jangka dawa marang ekuitas ReShape Lifesciences, Inc.|Rasio utang jangka dawa marang ekuitas Silk Road Medical Inc (SILK)